Published: 2019 November 08
Updated : 2022 November 04

Prurigo Nodularis Treatment Market

SKU : PH2151
180 pages
Report Summary
Table of Contents
List of Tables & Figures

Prurigo Nodularis Treatment Market is segmented By Product type (Corticosteroids, Anti-histamines, Emollients, Capsaicin cream, Others), By End-user (Hospital pharmacies, Retail pharmacies, Online pharmacies), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2022-2029

Prurigo Nodularis Treatment Market

Prurigo Nodularis Treatment Market size was valued at USD million in 2021 and is estimated to reach USD million by 2029, growing at a CAGR of 3.6% during the forecast period (2022-2029). Prurigo nodularis (PN) is a skin disease that causes hard, itchy lumps to form on the skin. An intense itching causes people to scratch till bleeding or pain. Prurigo nodularis may be a phenotypic presentation of several underlying diseases like atopic dermatitis, chronic kidney-related pruritus, and neurological diseases.

As per DataM Intelligence, Prurigo Nodularis Treatment Market study analysis offers an in-depth outlook on the market containing quantitative and qualitative data. It gives an outlook and forecast of the global market based on market segmentation. It also provides global Prurigo Nodularis Treatment Market size, and growth, along with the latest trends, opportunities, and forecast till 2029 for the global market with esteem to major countries such as the United States, Canada, Brazil, Germany, Italy, Spain, United Kingdom, Russia, European countries, United Arab Emirates, Saudi Arabia, South Africa, Japan, China, India, South Korea, Australia, and rest of the countries over the globe.

Among all regions, the North American region is expected to hold the largest share of the global market over the forecast period. Prurigo Nodularis Treatment Market in the United States and Canada produces the utmost share. Whereas the European Prurigo Nodularis Treatment Market is projected to continue its presence globally during the period of 2022- 2029.

Prurigo Nodularis Treatment Market Scope



Market CAGR


Segments Covered

By Product Type, By Distribution Channels, By Route of Administration, and By Region

Report Insights Covered

Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights.

Fastest Growing Region

Asia Pacific

Largest Market Share 

North America

To know more insights into Market, Get Our Sample Brochure

Market Dynamics

The major driving forces are favorable regulations and initiatives for orphan drug development in various regions, increasing healthcare expenditure, the rarity of the disease, and rising demand for prominent orphan drugs used to treat rare diseases.

The ongoing research on treating prurigo nodularis is pushing the market’s growth.

The presence of an increased number of research and development activities is expected to drive the market over the forecast period (2022-2029); for instance, according to the Clinical Trials gov. currently, two studies are ongoing for the intervention of prurigo nodularis such as a phase 2b/3, randomized, double-blind, placebo-controlled, 2-arm, efficacy and safety study in prurigo nodularis (PN) with Nalbuphine ER tablets for pruritus relief through itch-scratch modulation (prism study) sponsored by Trevi Therapeutics and is expected to be completed on February 28, 2023, and a randomized, single-dose, open-label, parallel-group study in healthy volunteers to assess the relative bioavailability of a subcutaneous dose of Nemolizumab when administered with auto-injector compared to dual-chamber syringe sponsored by Galderma R&D, estimated to be completed on January 31, 2023. Furthermore, five different studies are recruiting, propelling the global market growth. 

The availability of alternative treatment options slows the Prurigo Nodularis Treatment market growth.

The availability of alternative treatment options is hindering market growth. For instance, Pimecrolimus was as effective as hydrocortisone and offered an alternative topical treatment option that may be implemented in a long-term regimen. Phototherapy can be used to treat several inflammatory skin conditions and is a therapeutic alternative for patients with multiple comorbidities or generalized prurigo nodularis. 

Industry analysis.

The prurigo nodularis treatment market report will provide an in-depth analysis of the market based on various industry factors such as porter`s five forces, research and developments, epidemiology, regulatory, pricing, pipeline analysis, Etc.

COVID-19 Impact Analysis

COVID-19 is an atypical health concern that has profoundly impacted the global prurigo nodularis treatment market growth. In the course of the outbreak, restrictions were imposed by different regulatory bodies for controlling the spread of the infection regarding the socializing of people, which made it difficult to get regular healthcare check-ups on time leaving many cases of prurigo nodularis undetected. Moreover, the restrictions on transportation affected the import and export, affecting the supply chain of many market players, overall reducing the availability of prurigo nodularis treatment in the market, reducing sales, and negatively impacting the market growth globally. 

Segment Analysis

 The corticosteroid creams segment is estimated to oppress the market during the forecast period (2022-2029).

The corticosteroid creams segment is expected to witness substantial growth during the forecast years (2022-2029). Considerable segmental growth can be attributed to the advantages possessed by these creams. These topical corticosteroids control the spread of fungal skin infections and decrease inflammation to a greater extent. Also, when applied externally on the body surface, creams provide faster relief than oral tablets, which require time to show outcomes. 

Geographical Analysis

North America is predicted to hold most of the market share.

North America dominated the global prurigo nodularis treatment market in 2021. It is assumed to oppress the global nodularis treatment market over the forecast period (2022-2029) owing to the presence of key market players in this region. For instance, Pfizer, Menlo Therapeutics Inc., Celgene Corporation and Trevi Therapeutics. These key players hold most of the market share and ensure that North America dominates the global prurigo nodularis treatment market. Furthermore, North America has the most advanced and robust infrastructure with good healthcare cost reimbursement policies fueling its command over the global market. 

Competitive Landscape 

The major players operating in the global prurigo nodularis treatment market are Menlo Therapeutics Inc., Pfizer, Kiniksa Pharmaceuticals, Ltd., GlaxoSmithKline, Galderma, Trevi Therapeutics, and Celgene Corporation. The key players are adopting various strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the growth of the prurigo nodularis treatment market globally. For instance, on June 09, 2022, Pfizer acquired ReViral. Also, on March 11, 2022, Pfizer acquired Arena Pharmaceuticals.

Pfizer Inc.


Pfizer is an American multinational pharmaceutical and biotechnology corporation founded in 1849 and headquartered in the United States. Pfizer is continuously researching and developing new drug products for various diseases.

Product Portfolio

Pfizer`s prurigo nodularis treatment product portfolio has CIBINQO.

The prurigo nodularis treatment market report would provide access to approximately 40+ market data tables, 45+ figures, and in the range of 200 (approximate) pages


Frequently Asked Questions

What is the Projected CAGR value of the Prurigo Nodularis Treatment Market ?

Prurigo Nodularis Treatment Market is expected to grow at a CAGR of 3.6% during the forecasting period 2022-2029.

Which region controlled the global market during 2022-2029?

North America region Controls the Prurigo Nodularis Treatment Market during 2022-2029.

Which is the fastest growing region in the Prurigo Nodularis Treatment Market ?

Among all regions, Asia Pacific is the fastest growing market share during the forecast period.

Trending Topics

Paraganglioma Treatment Market

Phenylketonuria Treatment Market

Buy this report
Single User
Multiple User
Enterprise User
Proceed to Buy